{"entity":{"type":"insider","cik":"0001417894","url":"/insider/0001417894","json_url":"/insider/0001417894.json","name":"Rogers Michael D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":5,"first":"2008-11-05","last":"2011-05-11","span_basis":"filed_date"},"name_variants":[{"name":"Rogers Michael D.","source":"filing","n_filings":5,"first_seen":"2008-11-05","last_seen":"2011-05-11"}],"transactions":[{"id":9162345,"accession":"0001192482-11-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-11-000123","line_url":"/filing/0001192482-11-000123#line-2","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":109.08,"price_display":"109.08","price_state":"stated","total_value":1090800.0,"total_display":"1,090,800.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":8957070,"accession":"0001192482-11-000108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-11-000108","line_url":"/filing/0001192482-11-000108#line-2","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":99.0034,"price_display":"99.00","price_state":"stated","total_value":1980068.0,"total_display":"1,980,068.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-27","filed_date":"2011-04-29","scope":"insider"},{"id":3604718,"accession":"0001192482-08-000402","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001192482-08-000402","line_url":"/filing/0001192482-08-000402#line-8","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":701.0,"shares_display":"701","price_per_share":18.65,"price_display":"18.65","price_state":"stated","total_value":13073.65,"total_display":"13,073.65","shares_owned_after":1700.0,"shares_owned_after_display":"1,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":3604716,"accession":"0001192482-08-000402","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001192482-08-000402","line_url":"/filing/0001192482-08-000402#line-7","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":18.75,"price_display":"18.75","price_state":"stated","total_value":11250.0,"total_display":"11,250.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":3604714,"accession":"0001192482-08-000402","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001192482-08-000402","line_url":"/filing/0001192482-08-000402#line-6","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":499.0,"shares_display":"499","price_per_share":18.69,"price_display":"18.69","price_state":"stated","total_value":9326.31,"total_display":"9,326.31","shares_owned_after":1201.0,"shares_owned_after_display":"1,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":3604713,"accession":"0001192482-08-000402","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001192482-08-000402","line_url":"/filing/0001192482-08-000402#line-5","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.62,"price_display":"18.62","price_state":"stated","total_value":7448.0,"total_display":"7,448.00","shares_owned_after":2501.0,"shares_owned_after_display":"2,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":3604712,"accession":"0001192482-08-000402","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-08-000402","line_url":"/filing/0001192482-08-000402#line-4","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.71,"price_display":"18.71","price_state":"stated","total_value":5613.0,"total_display":"5,613.00","shares_owned_after":601.0,"shares_owned_after_display":"601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":3604710,"accession":"0001192482-08-000402","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-08-000402","line_url":"/filing/0001192482-08-000402#line-3","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.7,"price_display":"18.70","price_state":"stated","total_value":5610.0,"total_display":"5,610.00","shares_owned_after":901.0,"shares_owned_after_display":"901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":3604708,"accession":"0001192482-08-000402","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-08-000402","line_url":"/filing/0001192482-08-000402#line-2","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.63,"price_display":"18.63","price_state":"stated","total_value":1863.0,"total_display":"1,863.00","shares_owned_after":2401.0,"shares_owned_after_display":"2,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":3604705,"accession":"0001192482-08-000402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-08-000402","line_url":"/filing/0001192482-08-000402#line-1","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":18.72,"price_display":"18.72","price_state":"stated","total_value":18.72,"total_display":"18.72","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348716,"accession":"0001192482-08-000401","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-29","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","shares_owned_after":14172.0,"shares_owned_after_display":"14,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348712,"accession":"0001192482-08-000401","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-28","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1672.0,"shares_display":"1,672","price_per_share":18.25,"price_display":"18.25","price_state":"stated","total_value":30514.0,"total_display":"30,514.00","shares_owned_after":7700.0,"shares_owned_after_display":"7,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348709,"accession":"0001192482-08-000401","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-27","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1430.0,"shares_display":"1,430","price_per_share":18.35,"price_display":"18.35","price_state":"stated","total_value":26240.5,"total_display":"26,240.50","shares_owned_after":4770.0,"shares_owned_after_display":"4,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348705,"accession":"0001192482-08-000401","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-26","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1080.0,"shares_display":"1,080","price_per_share":18.12,"price_display":"18.12","price_state":"stated","total_value":19569.6,"total_display":"19,569.60","shares_owned_after":11592.0,"shares_owned_after_display":"11,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348701,"accession":"0001192482-08-000401","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-25","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":18.5,"price_display":"18.50","price_state":"stated","total_value":11100.0,"total_display":"11,100.00","shares_owned_after":3300.0,"shares_owned_after_display":"3,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348696,"accession":"0001192482-08-000401","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-24","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":18.24,"price_display":"18.24","price_state":"stated","total_value":10944.0,"total_display":"10,944.00","shares_owned_after":9372.0,"shares_owned_after_display":"9,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348693,"accession":"0001192482-08-000401","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-23","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":18.21,"price_display":"18.21","price_state":"stated","total_value":10926.0,"total_display":"10,926.00","shares_owned_after":10072.0,"shares_owned_after_display":"10,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348689,"accession":"0001192482-08-000401","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-22","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":18.14,"price_display":"18.14","price_state":"stated","total_value":10884.0,"total_display":"10,884.00","shares_owned_after":10792.0,"shares_owned_after_display":"10,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348685,"accession":"0001192482-08-000401","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-21","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.32,"price_display":"18.32","price_state":"stated","total_value":7328.0,"total_display":"7,328.00","shares_owned_after":6200.0,"shares_owned_after_display":"6,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348679,"accession":"0001192482-08-000401","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-20","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.27,"price_display":"18.27","price_state":"stated","total_value":7308.0,"total_display":"7,308.00","shares_owned_after":6900.0,"shares_owned_after_display":"6,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348676,"accession":"0001192482-08-000401","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-19","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.26,"price_display":"18.26","price_state":"stated","total_value":7304.0,"total_display":"7,304.00","shares_owned_after":7300.0,"shares_owned_after_display":"7,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348671,"accession":"0001192482-08-000401","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-18","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.07,"price_display":"18.07","price_state":"stated","total_value":7228.0,"total_display":"7,228.00","shares_owned_after":12972.0,"shares_owned_after_display":"12,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348667,"accession":"0001192482-08-000401","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-17","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.05,"price_display":"18.05","price_state":"stated","total_value":7220.0,"total_display":"7,220.00","shares_owned_after":13372.0,"shares_owned_after_display":"13,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348663,"accession":"0001192482-08-000401","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-16","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.02,"price_display":"18.02","price_state":"stated","total_value":7208.0,"total_display":"7,208.00","shares_owned_after":13772.0,"shares_owned_after_display":"13,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348660,"accession":"0001192482-08-000401","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-15","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.43,"price_display":"18.43","price_state":"stated","total_value":5529.0,"total_display":"5,529.00","shares_owned_after":3900.0,"shares_owned_after_display":"3,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348657,"accession":"0001192482-08-000401","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-14","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.4,"price_display":"18.40","price_state":"stated","total_value":5520.0,"total_display":"5,520.00","shares_owned_after":4200.0,"shares_owned_after_display":"4,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348652,"accession":"0001192482-08-000401","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-13","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.29,"price_display":"18.29","price_state":"stated","total_value":5487.0,"total_display":"5,487.00","shares_owned_after":6600.0,"shares_owned_after_display":"6,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348651,"accession":"0001192482-08-000401","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-12","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":18.58,"price_display":"18.58","price_state":"stated","total_value":3716.0,"total_display":"3,716.00","shares_owned_after":3001.0,"shares_owned_after_display":"3,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348646,"accession":"0001192482-08-000401","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-11","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":18.13,"price_display":"18.13","price_state":"stated","total_value":3626.0,"total_display":"3,626.00","shares_owned_after":11392.0,"shares_owned_after_display":"11,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348642,"accession":"0001192482-08-000401","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-10","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":18.08,"price_display":"18.08","price_state":"stated","total_value":3616.0,"total_display":"3,616.00","shares_owned_after":12772.0,"shares_owned_after_display":"12,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348637,"accession":"0001192482-08-000401","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-9","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120.0,"shares_display":"120","price_per_share":18.2,"price_display":"18.20","price_state":"stated","total_value":2184.0,"total_display":"2,184.00","shares_owned_after":10692.0,"shares_owned_after_display":"10,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348633,"accession":"0001192482-08-000401","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-8","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.59,"price_display":"18.59","price_state":"stated","total_value":1859.0,"total_display":"1,859.00","shares_owned_after":2901.0,"shares_owned_after_display":"2,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348629,"accession":"0001192482-08-000401","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-7","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.38,"price_display":"18.38","price_state":"stated","total_value":1838.0,"total_display":"1,838.00","shares_owned_after":4570.0,"shares_owned_after_display":"4,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348625,"accession":"0001192482-08-000401","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-6","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.37,"price_display":"18.37","price_state":"stated","total_value":1837.0,"total_display":"1,837.00","shares_owned_after":4670.0,"shares_owned_after_display":"4,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348621,"accession":"0001192482-08-000401","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-5","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.23,"price_display":"18.23","price_state":"stated","total_value":1823.0,"total_display":"1,823.00","shares_owned_after":9972.0,"shares_owned_after_display":"9,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348612,"accession":"0001192482-08-000401","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-4","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.1,"price_display":"18.10","price_state":"stated","total_value":1810.0,"total_display":"1,810.00","shares_owned_after":12672.0,"shares_owned_after_display":"12,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348608,"accession":"0001192482-08-000401","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-3","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99.0,"shares_display":"99","price_per_share":18.55,"price_display":"18.55","price_state":"stated","total_value":1836.45,"total_display":"1,836.45","shares_owned_after":3201.0,"shares_owned_after_display":"3,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":2348603,"accession":"0001192482-08-000401","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-08-000401","line_url":"/filing/0001192482-08-000401#line-2","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70.0,"shares_display":"70","price_per_share":18.39,"price_display":"18.39","price_state":"stated","total_value":1287.3,"total_display":"1,287.30","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-13","filed_date":"2008-11-17","scope":"insider"},{"id":3885897,"accession":"0001192482-08-000366","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001192482-08-000366","line_url":"/filing/0001192482-08-000366#line-5","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":18.25,"price_display":"18.25","price_state":"stated","total_value":7300.0,"total_display":"7,300.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-04","filed_date":"2008-11-05","scope":"insider"},{"id":3885896,"accession":"0001192482-08-000366","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001192482-08-000366","line_url":"/filing/0001192482-08-000366#line-4","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.02,"price_display":"18.02","price_state":"stated","total_value":1802.0,"total_display":"1,802.00","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-04","filed_date":"2008-11-05","scope":"insider"},{"id":3885894,"accession":"0001192482-08-000366","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-08-000366","line_url":"/filing/0001192482-08-000366#line-2","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001417894","owner_name":"Rogers Michael D.","owner_url":"/insider/0001417894","role":"Officer (Chief Development Officer)","officer_title":"Chief Development Officer","security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1578.0,"shares_display":"1,578","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":28404.0,"total_display":"28,404.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-03","filed_date":"2008-11-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001301081","name":"Pharmasset Inc","url":"/issuer/0001301081","role":"Officer (Chief Development Officer)","n_filings":5,"first_seen":"2008-11-05","last_seen":"2011-05-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001417894","retrieved_at":"2026-08-22T03:58:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}